An Individualized-health eLibrary App for People With Multiple Sclerosis
Part of paid clinical trials in Champaign, Illinois.
- Sponsor
- University of Illinois at Urbana-Champaign
- Study ID
- NCT05124600
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SavvyHealth — DEVICEParticipants will use the new app, SavvyHealth, for 21 days.
Study Details
The purpose of this study is to assess the effectiveness after using a new individualized-health e-library app named SavvyHealth among people with multiple sclerosis.
Key Dates
- Start date
- Oct 25, 2021
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: SavvyHealthParticipants will use the new app, SavvyHealth, for 21 days.
- No Intervention: Waiting listParticipants will be on the waiting list.
Primary Outcome Measure
MS Self-management Scale [ Time Frame: Through study completion, an average of 1 week ]
Central Contacts
- Chungyi Chiu217-244-6435
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Illinois Urbana-Champaign | Champaign | Illinois | 61820 |
Find similar trials in Champaign, IL
By condition
By specialty
By research site
Related Studies
- Quality Improvement and Practice Based Research in Neurology Using the EMRPHASE4 · Enrolling By Invitation · Endeavor Health · Evanston, Illinois
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Exercise Training for Managing Major Depressive Disorder in Multiple SclerosisRecruiting · University of Illinois at Chicago · Chicago, Illinois
- Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPHASE4 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · New Haven, Connecticut